Benzinga | Nov 9, 2021 11:28AM EST

HC Wainwright & Co. Maintains Buy on Paratek Pharmaceuticals, Lowers Price Target to $27

HC Wainwright & Co. analyst Ed Arce maintains Paratek Pharmaceuticals (NASDAQ:PRTK) with a Buy and lowers the price target from $28 to $27.